ASPEN PHARMACARE HOLDINGS LIMITED - No Change Statement and Notice of Annual General Meeting - 7 December 2015

No Change Statement and Notice of Annual General Meeting - 7 December 2015

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen Holdings" or "the Company")


NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING
– 7 DECEMBER 2015

Shareholders are advised that the Company’s Integrated Report for the year ended 30 June 2015 has
been finalised and that this report and the notice of the annual general meeting (“AGM”) to be held
at its Durban offices on 7 December 2015 will be posted to shareholders in due course. The
Integrated Report, notice of AGM and the following documents are also available online at the
Company’s website www.aspenpharma.com:

   -   Corporate Governance Statement and reports of the Aspen Audit & Risk and Social & Ethics
       committees for the 2015 financial year (“Unabridged Corporate Governance Statement”);
   -   the Aspen Group’s Sustainability Report for the 2015 financial year (“Sustainability Report”);
       and
   -   the Annual Financial Statements the 2015 financial year (“AFS”).

 The AFS contain no modifications to the reviewed provisional results which were published on
 SENS on 9 September 2015. The AFS were audited by PricewaterhouseCoopers Inc. Their
 unqualified report is available for inspection at the Company’s registered office.

 Notice is hereby given that the 17th annual general meeting of the shareholders of the Company will
 be held at Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge Office Park,
 Durban, Kwa-Zulu Natal, on Monday, 7 December 2015 at 10:00.

 Shareholders who, for whatever reason, experience postal delays and who do not receive the
 notice of the AGM in time to submit proxy forms to the Company’s share transfer secretaries
 (Computershare) are requested to access the notice of AGM and other documents referred to
 above on the Company’s website www.aspenpharma.com. A printable version of these
 documents in PDF format can also be emailed to shareholders upon request to the Company
 Secretary – rverster@aspenpharma.com or +27 31 580 8624.


 Durban
 3 November 2015

 Sponsor
 Investec Bank Limited

Date: 03/11/2015 12:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.